Basit Salik

300 Herston Road
Herston, QLD 4006, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

The PERKs of ER homeostasis for hematopoietic stem cells.

The PERKs of ER homeostasis for hematopoietic stem cells.

Journal: Blood

Published: August 14, 2025

An inflammatory and quiescent HSC subpopulation expands with age in humans.

An inflammatory and quiescent HSC subpopulation expands with age in humans.

Journal: Genome biology

Published: August 12, 2025

Synergistic targeting of eIF4A-mediated translation initiation and apoptosis in acute myeloid leukemia.

Synergistic targeting of eIF4A-mediated translation initiation and apoptosis in acute myeloid leukemia.

Journal: Blood neoplasia

Published: March 07, 2025

Inhibition of CD39 unleashes macrophage antibody-dependent cellular phagocytosis against B-cell lymphoma.

Inhibition of CD39 unleashes macrophage antibody-dependent cellular phagocytosis against B-cell lymphoma.

Journal: Leukemia

Published: September 30, 2022

Targeting immune checkpoints in hematological malignancies.

Targeting immune checkpoints in hematological malignancies.

Journal: Journal of hematology & oncology

Published: June 05, 2020

Regional Variation in Epidermal Susceptibility to UV-Induced Carcinogenesis Reflects Proliferative Activity of Epidermal Progenitors.

Regional Variation in Epidermal Susceptibility to UV-Induced Carcinogenesis Reflects Proliferative Activity of Epidermal Progenitors.

Journal: Cell reports

Published: October 30, 2019

Targeting RSPO3-LGR4 Signaling for Leukemia Stem Cell Eradication in Acute Myeloid Leukemia.

Targeting RSPO3-LGR4 Signaling for Leukemia Stem Cell Eradication in Acute Myeloid Leukemia.

Journal: Cancer cell

Published: March 07, 2019

miR-101 suppresses the development of MLL-rearranged acute myeloid leukemia.

miR-101 suppresses the development of MLL-rearranged acute myeloid leukemia.

Journal: Haematologica

Published: February 23, 2019

JMJD1C-mediated metabolic dysregulation contributes to HOXA9-dependent leukemogenesis.

JMJD1C-mediated metabolic dysregulation contributes to HOXA9-dependent leukemogenesis.

Journal: Leukemia

Published: April 09, 2018

Showing 1-9 of 9

Last Updated: 09/26/2026